Published Date: 2024-09-06 Pages: 93 USD 4350.00 (Single User License) The global market for Tirzepatide Injection was valued at US$ 16505 million in the year 2024 and is projected to reach a revised size of US$ 51045 million by 2031, growing at a CAGR of 15.5% during the forecast period
Serious Side Effects : Although rare, some individuals may encounter more severe reactions, including pancreatitis, acute kidney injury, or allergic responses
Today, every leading GLP-1 oral tablet manufacturer in India is playing a crucial role in meeting international demand through advanced manufacturing, regulatory compliance, and strong export capabilities
Coordinate care across endocrinology, nutrition, behavioral health, and diabetes education
eLife (2019)
So the big question becomes: could these medicines also influence inflammation directly in the jointin addition to their established roles in weight and metabolic pathways? The detection of GLP-1 in the joint environment provides interesting perspectives for next steps in translational research: Do GLP-1 therapies reach the joint at therapeutically relevant concentrations
